Orphan Drugs for Rare Diseases: Grounds for Special Status-Reference-Cited by-同舟云学术

Orphan Drugs for Rare Diseases: Grounds for Special Status

Published:2012-02-23 Issue:3 Volume:73 Page:115-119
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Picavet Eline¹,Dooms Marc²,Cassiman David³,Simoens Steven¹

Affiliation:

1. Research Centre for Pharmaceutical Care and Pharmaco-economics; Faculty of Pharmaceutical Sciences; Katholieke Universiteit Leuven; Leuven; Belgium

2. Hospital Pharmacy; University Hospital Leuven; Leuven; Belgium

3. Department of Hepatology; University Hospital Leuven; Leuven; Belgium

Publisher

Wiley

Subject

Drug Discovery

Reference40 articles.

1. The increasing role of health economic evaluations in drug development;Annemans;Drug Dev Res,2010

2. Ethical aspects on rare diseases;Barrera;Adv Exp Med Biol,2010

3. Exploring emerging technologies using metaphors--a study of orphan drugs and pharmacogenomics;Boon;Soc Sci Med,2008

4. Commissioning for rare diseases: view from the frontline;Burls;BMJ,2005

5. Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy;Clarke;CMAJ,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Literature Review on Health Emigration in Rare Diseases—A Machine Learning Perspective;International Journal of Environmental Research and Public Health;2023-01-30

2. A systematic review of moral reasons on orphan drug reimbursement;Orphanet Journal of Rare Diseases;2021-06-30

3. How to Value Orphan Drugs? A Review of European Value Assessment Frameworks;Frontiers in Pharmacology;2021-05-12

4. Opportunities and barriers for innovation and entrepreneurship in orphan drug development;Technological Forecasting and Social Change;2020-12

5. Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives;Journal of Law and the Biosciences;2018-08-31